Payer

By  Dr. Liz Kwo 12:00 pm September 11, 2020
About the author: Dr. Liz Kwo is currently the staff VP of clinical data analytics at Anthem, and previously cofounded and served as CEO of telemedicine second opinion company InfiniteMD. She received an MD from Harvard Medical, an MBA from Harvard Business School and an MPH from the Harvard T.H. Chan School of Public Health. COVID-19 has reshaped the way humans interact with technology in...
By  Dave Muoio 03:18 pm September 4, 2020
Connected-care-device and services company VivaLNK has partnered with healthcare engineering and tech firm Mazzetti to supply pop-up hospitals, clinics and senior centers with patient monitoring tools. These include VivaLNK's wearable vitals sensors and a connected provider platform, which the companies say will help reduce unnecessary disease exposures within these settings. “As the pandemic...
By  Dave Muoio 11:36 am September 2, 2020
Abbott announced yesterday that its recently cleared FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system is now covered by the Centers for Medicare and Medicaid Services (CMS), and available to Medicare beneficiaries with diabetes who meet eligibility criteria. Indicated for diabetes management in patients aged four years or older, the updated version of Abbott's system can...
By  Dave Muoio 11:35 am August 26, 2020
Real-world evidence (RWE) technology startup Aetion has extended last year's $63 million Series B with a new $19 million raise. The funds come as strategic investments from Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates, all three of which are new supporters of the company. WHAT IT DOES Founded in 2013, the company's platform provides insights from RWE to decision-makers...
By  Laura Lovett 03:17 pm August 25, 2020
Alphabet’s life science subsidiary Verily is jumping into the health insurance game with the launch of its new venture Coefficient Insurance Company.  The tech-enabled payer will be backed by Swiss Re Corporate Solutions, which specializes in data-driven risk assessments.  Coefficient, which is categorized as a Verily subsidiary, is targeted at self-funded employers and is pitched as stop-loss...
By  Dave Muoio 01:10 pm August 19, 2020
The United States Postal Service has been at the heart of a bitter partisan divide over the last few months of COVID-19 and the U.S. election season. Prominent Democratic politicians have alleged that recent reforms and administrative changes ushered by recently appointed Postmaster General Louis DeJoy have led to widespread service delays across the country. At the same time, President Donald...
By  Dave Muoio 01:35 pm August 18, 2020
U.S. consumers want to understand how and why their personal health data is being used by organizations, and may change their data sharing behaviors if they believe the information is being used to improve health outcomes for themselves or others, according to recent survey from health data intelligence firm W2O. Conducted in two 1,000-person waves in September 2019 and May 2020, the poll...
By  Dave Muoio 04:15 pm August 12, 2020
A new investigation of roughly two million Medicare beneficiary claims suggests that machine learning (ML) could be used to predict which patients are at greatest risk of severe respiratory infections, and to place them in more appropriate care facilities in their area. The study was published online in the American Journal of Managed Care and funded by the HEALTH[at]SCALE Corporation, a...
By  Dave Muoio 01:56 pm August 10, 2020
The past few months have seen tech companies, healthcare organizations, employee-benefits vendors and others toss their hat into a fast-growing market for "return-to-work" COVID-19 health-monitoring services. Today CVS Health and Salesforce, two of the bigger names in that race, have announced plans to integrate their offerings into a single digital, data-driven testing and monitoring program....
By  Dave Muoio 12:14 pm July 29, 2020
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers. The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...